: Lucintel Forecasts the Global Ebola Drug and Vaccine Market to Reach $168.7 million by 2030
: Lucintel Forecasts the Global Ebola Drug and Vaccine Market to Reach $168.7 million by 2030
Blog Article
According to a market report by Lucintel, the future of the global Ebola drug and vaccine market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global Ebola drug and vaccine market is expected to reach an estimated $168.7 million by 2030 from $37.3 million in 2023, at a CAGR of 28.6% from 2024 to 2030. The major drivers for this market are growing prevalence of infectious diseases and supportive government initiatives towards Ebola research and development of Ebola drugs and vaccines.
A more than 150-page report to understand trends, opportunity and forecast in Ebola drug and vaccine market to 2030 by novel drug type (zmapp, favipiravir, gs-5734, tkm-Ebola, and avi-7537), vaccine type (cad3-zebov, rvsv-zebov, and others), strain type (zaire, sudan, tai forest, reston, and bundibugyo virus), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that zaire is expected to witness the highest growth over the forecast period.
Download sample by clicking on Ebola drug and vaccine market
North America will remain the largest region due to the growing prevalence of zoonotic diseases, the rising adoption of advanced medical technologies, and the presence of well-established healthcare infrastructure in the region.
Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, NanoViricides, NewLink Genetics are the major suppliers in the Ebola drug and vaccine market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Combat Drone Market
Confined Space Drone Market
Crop Inspection Drone Market
Custom Drone Market
Detachable Drone Market
Fixed-Wing Drone Market